In an exclusive interview with Moneycontrol, Dr Reddy's CFO, M.V. Narasimham highlighted the company's plans on moving up the ...

Over the years, the brothers focused on acquisitions, expansion and margins to make Torrent ... Over the years, it has ...

Dr. Reddy's Laboratories Limited ( NYSE: RDY) Q2 2025 Earnings Conference Call November 5, 2024 9:00 AM ET Richa Periwal - Head of Investor Relations MV Narasimham - Chief Financial Officer Erez ...

He won’t give timelines about development of the drugs with Sanofi, which is still deciding ... on topics including regulation, mergers and acquisitions, and the latest clinical developments.

Based on previous success rates of ∼20%—and on typical development timelines of seven to eight ... such as Paris-based Sanofi-aventis, GlaxoSmithKline (GSK), Merck and Wyeth, of Madison ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...

Crossmark Global Holdings Inc. increased its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 23.7% during the ...

Sanofi (Symbol: SNY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

He added that while there was no timeline for how long Sanofi would be involved in Opella, "we expect to be involved and in partnership for a long time". Opella employs 11,000 people globally and ...